|
UBA3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.517800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.661400E-03 |
| Normal-vs-Stage2 |
1.828560E-01 |
| Normal-vs-Stage3 |
9.973000E-01 |
| Normal-vs-Stage4 |
6.369500E-02 |
| Stage1-vs-Stage2 |
7.971200E-01 |
| Stage1-vs-Stage3 |
4.833500E-02 |
| Stage1-vs-Stage4 |
7.256200E-03 |
| Stage2-vs-Stage3 |
2.704400E-01 |
| Stage2-vs-Stage4 |
1.296140E-02 |
| Stage3-vs-Stage4 |
1.361620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.019770E-02 |
| Normal-vs-AfricanAmerican |
2.664000E-02 |
| Normal-vs-Asian |
9.748200E-01 |
| Caucasian-vs-AfricanAmerican |
7.387200E-01 |
| Caucasian-vs-Asian |
3.957600E-01 |
| AfricanAmerican-vs-Asian |
3.719400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.563800E-02 |
| Normal-vs-Female |
1.499920E-03 |
| Male-vs-Female |
4.966400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.655800E-01 |
| Normal-vs-Extreme_Weight |
7.509800E-02 |
| Normal-vs-Obese |
5.800000E-02 |
| Normal-vs-Extreme_Obese |
4.293400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.318000E-01 |
| Normal_Weight-vs-Obese |
4.662200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.106000E-01 |
| Extreme_Weight-vs-Obese |
7.399600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.902000E-01 |
| Obese-vs-Extreme_Obese |
9.287600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.138300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.718500E-03 |
| Normal-vs-Age(61-80Yrs) |
2.404300E-02 |
| Normal-vs-Age(81-100Yrs) |
6.230000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.167600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.188800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.486400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.804800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.047400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.617400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.40049999999936E-05 |
| Normal-VS-Type2 PRCC |
3.690200E-01 |
| Normal-VS-KIRP CIMP |
5.916800E-01 |
| Normal-VS-Unclassified PRCC |
8.888200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.27999999780471E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.161560E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.414600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.053400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.588010E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.954000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.308800E-01 |
| Normal-vs-N1 |
3.901600E-01 |
| Normal-vs-N2 |
3.628400E-02 |
| N0-vs-N1 |
5.531400E-01 |
| N0-vs-N2 |
1.603620E-01 |
| N1-vs-N2 |
1.052600E-01 |
|
|
